Authorised Therapeutic confirmatory (Phase III) Cancer surgery

BCS-ORL - Evaluation of the superficial cervical plexus block in oncological throat and neck surgery

EU CTIS ID: 2024-510942-15-00

What this study is testing

The objective of this study is the reduction in the quantity of IV morphine (titration + PCA morphine) during the first 24 postoperative hours via a locoregional anesthesia technique in patients undergoing throat and neck cancer surgery.

  • Therapeutic confirmatory (Phase III)

A plain-language read of the study's public EU CTIS listing. The study team confirms the details.

Who can take part

You may be able to join if

  • Adult patient undergoing ENT cancer surgery with cervicotomy
  • Patient having received oral information from a doctor and signed written consent
  • Affiliation to a social security scheme, Universal Medical Coverage (CMU)

You likely can't join if

  • Patient refusal
  • Patient under AME
  • Altered mental faculties or patient unable to give consent
  • Allergy to local anesthetics
  • Severe respiratory pathology (altered respiratory function tests with 50% < FEV1 < 80%, FEV1/FVC < 70%, COPD stage 2 or more)
  • Preoperative SpO2 less than 92% in ambient air
See the full eligibility criteria
Who can join
  • Adult patient undergoing ENT cancer surgery with cervicotomy
  • Patient having received oral information from a doctor and signed written consent
  • Affiliation to a social security scheme, Universal Medical Coverage (CMU)
What rules you out
  • Patient refusal
  • Patient under AME
  • Altered mental faculties or patient unable to give consent
  • Allergy to local anesthetics
  • Severe respiratory pathology (altered respiratory function tests with 50% < FEV1 < 80%, FEV1/FVC < 70%, COPD stage 2 or more)
  • Preoperative SpO2 less than 92% in ambient air
  • Left heart failure NYHA 3 or more, impaired LVEF < 30% or less
  • Lower respiratory infection in the month preceding surgery
  • History of ENT cancer surgery with cervical lymph node dissection
  • Pregnant or breastfeeding woman

The study team makes the final eligibility decision.

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.